Skip to main content
Clinical Trials/ACTRN12617000598381
ACTRN12617000598381
Active, not recruiting
未知

A pilot study to evaluate the effectiveness of daily 0.01% atropine eye drop therapy in modifying the progression of myopia, in Australian Children.

ions Eye Institute0 sites153 target enrollmentApril 27, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ions Eye Institute
Enrollment
153
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2017
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ions Eye Institute

Eligibility Criteria

Inclusion Criteria

  • Aged 6\-16 years
  • Myopia with spherical equivalent refractive error greater or equal to \-1\.5D in each eye
  • Documented myopic progression of greater or equal to \-0\.5D over the previous 12 months in either eye
  • Astigmatism less than \-1\.5D
  • An intraocular difference in spherical equivalent \< 1D
  • Corrected visual acuity greater than logMar 0\.2
  • Normal ocular health
  • No history of cardiac/respiratory disease
  • Willing and able to provide details of parents country of origin
  • Able to provide appropriate parental/carer consent

Exclusion Criteria

  • Children who are currently wearing or have worn orthokeratology lenses over the previous two years for myopia control.

Outcomes

Primary Outcomes

Not specified

Similar Trials